In our latest episode, we welcome Dr. Mikael Sodergren, Medical Cannabis Research Group Lead at Imperial College London and Managing Director at Sapphire Medical Clinics.
We examine how clinical trials and real-world evidence can be used to prove the efficacy of cannabis-based medicines, as well as the challenges associated with applying traditional licensing and regulatory models to these novel medicines.
